GO
Loading...

Big Pharma: Market Medicine?

On CNBC’s Squawk Box, billionaire investor Warren Buffett revealed that he’s adding to his position in the pharmaceuticals sector.

However, Buffett added that it's one area where he doesn't usually try to predict how individual companies will do in the future and that he might end up with a stake in a domestic drug company, especially since they make a lot of their money overseas, getting a boost from the weak U.S. dollar

What’s your interpretation?

I would keep an eye on Glaxo and Sanofi-Aventis, the two drug companies in which Mr. Buffett recently purchased shares, counsels Pete Najarian on CNBC’s “Closing Bell.” Also look at Johnson & Johnson , which Buffett has held for a while.

It seems that Buffett supports his position if he’s a large shareholder, Najarian explains. In other words, he continually seems to purchase when stock dips to a certain level. It’s almost like a Buffett "put".

And it’s worth noting, Mr. Buffett’s position in JNJ is very significant while his positions in GSK and SNY are fairly small.





Read More:

Warren Buffett to CNBC: U.S. Economy in Recession By "Common Sense Definition"

______________________________________________________
Got something to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to fastmoney@cnbc.com.

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET

Halftime Report

  • Bill Nygren, Oakmark Fund, explains why Apache, Bank of America and Google will be winners in 2015.

  • Nick Tiller, Sustainable America founder and chairman, tells CNBC's Kate Kelly oil prices are poised for a tradable rally. Tiller likes the Brent ETF and energy sector.

  • Discussing interesting trends contributing to the market's rally into year's end, with the FMHR trader Josh Brown and Dan Greenhaus, BTIG.